drugset / Trial / NCT03660813

Follicle Size and Oocyte Development

NCT03660813

Completed 200 enrolled Sheba Medical Center
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

Studies have shown that the follicles greater in diameter was most likely to have a mature oocyte that was capable of fertilization and best suited for development into a high-quality embryo. Smaller follicles showed lower rates ( 60%). Lately new triggering protocols have emerged aiming to improve the proportion of mature oocytes at the time of retrieval. The aim of this study is to learn the effects of the dual triggering compared to the standard hCG triggering on the oocyte development and quality as a function of the follicle size

Timeline

Start
2018-07-01
Primary completion
2021-08-01
Completion
2021-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Decapeptyl Unknown 0.1 mg
Background Ovidrel Protein / enzyme biologic 250 ug

Indications

No indication recorded.